Daewon Pharmaceutical Co. Ltd. (003220) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.034x

Based on the latest financial reports, Daewon Pharmaceutical Co. Ltd. (003220) has a cash flow conversion efficiency ratio of 0.034x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.21 Billion ≈ $6.24 Million USD) by net assets (₩270.98 Billion ≈ $183.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review how financially flexible is Daewon Pharmaceutical Co. Ltd. to assess the company's free cash flow relative to its total liabilities.

Daewon Pharmaceutical Co. Ltd. - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Daewon Pharmaceutical Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see 003220 company net worth for the company's overall valuation and market capitalisation.

Daewon Pharmaceutical Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daewon Pharmaceutical Co. Ltd. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
RTX A/S CO:RTX	0.041x
Patria Bank SA RO:PBK	0.240x
Khonburi Sugar Public Company Limited BK:KBS	0.252x
Hurco Companies Inc NASDAQ:HURC	0.019x
DEVEX Resources Ltd AU:DEV	-0.147x
GCL NEW ENERGY HD-0832 F:TJI	N/A
Caisse Regionale de Credit Agricole Mutuel Loire HauteLoire PA:CRLO	0.036x
Orian Sh.M. Ltd TA:ORIN	0.060x

Annual Cash Flow Conversion Efficiency for Daewon Pharmaceutical Co. Ltd. (2011–2025)

The table below shows the annual cash flow conversion efficiency of Daewon Pharmaceutical Co. Ltd. from 2011 to 2025. View current stock price of Daewon Pharmaceutical Co. Ltd. for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩274.58 Billion ≈ $186.08 Million	₩42.31 Billion ≈ $28.68 Million	0.154x	+46.01%
2024-12-31	₩284.58 Billion ≈ $192.85 Million	₩30.04 Billion ≈ $20.35 Million	0.106x	-46.09%
2023-12-31	₩264.26 Billion ≈ $179.09 Million	₩51.73 Billion ≈ $35.06 Million	0.196x	+46.13%
2022-12-31	₩248.77 Billion ≈ $168.58 Million	₩33.33 Billion ≈ $22.58 Million	0.134x	+30.54%
2021-12-31	₩218.40 Billion ≈ $148.01 Million	₩22.41 Billion ≈ $15.19 Million	0.103x	-12.49%
2020-12-31	₩212.77 Billion ≈ $144.19 Million	₩24.95 Billion ≈ $16.91 Million	0.117x	-22.67%
2019-12-31	₩204.22 Billion ≈ $138.39 Million	₩30.97 Billion ≈ $20.99 Million	0.152x	-30.60%
2018-12-31	₩183.20 Billion ≈ $124.15 Million	₩40.03 Billion ≈ $27.13 Million	0.219x	+761.41%
2017-12-31	₩168.13 Billion ≈ $113.94 Million	₩4.27 Billion ≈ $2.89 Million	0.025x	-80.23%
2016-12-31	₩162.01 Billion ≈ $109.79 Million	₩20.79 Billion ≈ $14.09 Million	0.128x	-26.10%
2015-12-31	₩148.66 Billion ≈ $100.75 Million	₩25.82 Billion ≈ $17.50 Million	0.174x	+33.89%
2014-12-31	₩134.51 Billion ≈ $91.16 Million	₩17.45 Billion ≈ $11.82 Million	0.130x	+29.76%
2013-12-31	₩123.25 Billion ≈ $83.53 Million	₩12.32 Billion ≈ $8.35 Million	0.100x	-18.36%
2012-12-31	₩112.92 Billion ≈ $76.53 Million	₩13.83 Billion ≈ $9.37 Million	0.122x	-29.04%
2011-12-31	₩103.92 Billion ≈ $70.42 Million	₩17.93 Billion ≈ $12.15 Million	0.173x	--

About Daewon Pharmaceutical Co. Ltd.

KO:003220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$115.62 Million

₩170.61 Billion KRW

Market Cap Rank

#18773 Global

#882 in Korea

Share Price

₩7960.00

Change (1 day)

-0.25%

52-Week Range

₩7240.00 - ₩13450.00

All Time High

₩23535.34